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CASE REPORTSNovel treatment for critical aortic stenosis with severe aortic root
calcification and coronary disease: Combined left internal thoracic
artery graft to left anterior descending coronary artery and
deployment of transcatheter aortic valve implantation valve under
direct visionNick Curzen, BM (Hons), PhD, FRCP,a,b Paul Diprose, BM, FRCSEd, FRCA,a Wendy George,a and
Geoff Tsang, MD, FRCS (CTh),a Southampton, United KingdomA 78-year-old woman with no previous cardiac history pre-
sented to her local hospital in acute pulmonary edema after
several weeks of increasing shortness of breath on exertion.
A systolic murmur was heard and a subsequent transtho-
racic echocardiogram showed preserved left ventricular
function and calcific aortic stenosis with a Doppler-
derived estimated pressure gradient of 70 mm Hg. She
was referred for consideration of surgical aortic valve
replacement and underwent coronary angiography as part
of the work-up. At fluoroscopy there was severe diffuse
circumferential calcification involving the aortic root and
ascending aorta (Figure 1), as well as an important stenosis
in the mid-left anterior descending (LAD), which itself was
heavily calcified and extremely tortuous. The case was dis-
cussed at a multidisciplinary team meeting and a conven-
tional aortic valve replacement was deemed unattractive
because of the degree of aortic root calcification. Further-
more, the appearance of the LAD made percutaneous treat-
ment of this lesion technically challenging. It therefore was
decided that surgery should be performed to replace the
aortic valve using a transcatheter aortic valve implantation
(TAVI) under direct vision, and graft the LAD artery using a
left internal thoracic conduit.
Surgery was performed through a median sternotomy on
cardiopulmonary bypass. The left internal thoracic artery
was harvested and sewn on to the LAD uneventfully. A
high transverse aortotomy then was performed and the
heavily calcified aortic valve was visualized. Several
calcific masses were removed from the root. A 26-mm
Edwards Sapien TAVI valve (Edwards Lifesciences, Irvine,
Calif) mounted on a transfemoral delivery system wasFrom the Wessex Cardiothoracic Centre,a University Hospital Southampton NHS
Foundation Trust, Southampton, United Kingdom; Faculty of Medicine,b Univer-
sity of Southampton, Southampton, United Kingdom.
Disclosures: Authors have nothing to disclose with regard to commercial support.
Received for publication May 8, 2013; accepted for publication July 19, 2013;
available ahead of print Sept 16, 2013.
Address for reprints: Nick Curzen, BM (Hons), PhD, FRCP, Wessex Cardiothoracic
Unit, University Hospital Southampton NHS Foundation Trust, Tremona Rd,
Southampton SO16 6YD, United Kingdom (E-mail: nick.curzen@uhs.nhs.uk).
J Thorac Cardiovasc Surg 2013;146:e53-4
0022-5223/$36.00
Copyright  2013 by The American Association for Thoracic Surgery
http://dx.doi.org/10.1016/j.jtcvs.2013.07.037
The Journal of Thoracic and Capositioned and deployed under direct vision (Figure 2),
and the aortotomy was closed with 4.0 Prolene (Ethicon,
Inc, Somerville, NJ) suture.
The procedure was uncomplicated and the patient had an
uneventful recovery apart from transient atrial fibrillation.
Post-procedure echocardiography confirmed successful
position and function of the TAVI valve.DISCUSSION
The role of TAVI in the treatment of severe aortic steno-
sis in symptomatic patients either unsuitable for conven-
tional aortic valve replacement, or at very high risk for
it, is now well established by high-quality randomized tri-
als.1,2 Recent modifications of the TAVI technique include
the transaortic approach for patients with restricted
vascular access, although issues relating to aortic
calcification and its distribution remain a concern in someFIGURE 1. Right anterior oblique fluoroscopic image showing extensive
calcification involving the aortic root and ascending aorta. The catheter is
sitting in the orifice of the right coronary artery.
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FIGURE 2. A, Image from head end showing aortotomy and transfemoral 26-mm Edwards Sapien TAVI valve being prepared for positioning under direct
vision. B, Close-up view through aortotomy showing TAVI valve after successful deployment.
Case Reportspatients.3 The combination of transaortic TAVI and coro-
nary bypass surgery also has been reported.4 We describe
a case in which the extent of circumferential aortic calcifi-
cation presented a considerable technical challenge for
conventional aortic valve surgery, but in a patient in
whom LAD disease also was believed to be very difficult
to manage by percutaneous coronary intervention. It there-
fore was decided, given our familiarity with TAVI, that we
should make use of the transfemoral TAVI valve and deliv-
ery system to replace the aortic valve at the same time the
left internal thoracic artery to LAD was performed, thus
avoiding the requirement for suturing at the level of the
dense aortic calcification. The utility of a TAVI valve inFrom the Vascular Surgery Unit, Department ‘‘Paride Stefanini,’’ Sapienza University
of Rome, Rome, Italy.
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vasc Surg. 2013;145:600-2.Four-year follow-up after thoracic endovascular aortic repair for
symptomatic thoracoabdominal aneurysm through the off-label use
of a bifurcated abdominal endograftMario Marino, MD, Holta Kasemi, MD, Enrico Sbarigia, MD, and Francesco Speziale, MD, Rome, ItalyThoracic endovascular aortic repair has become an alterna-
tive to the open surgical or to the hybrid approach for thor-
acoabdominal aortic aneurysm (TAAA) treatment.1
Fenestrated and branched endografts allow the exclusionof the aneurysm and perfusion of the visceral arteries. Un-
fortunately, these devices require from 4 to 6 weeks for
manufacture, an unsafely long wait for a symptomatic or
ruptured TAAA. In an emergency setting, the use of off-
the shelf devices of standardized design permits treatment
of more than 80% of TAAAs.2 Homemade devices have
been reported for urgent TAAA repair.3 In addition, the
chimney and sandwich endovascular techniques remain a
valid alternative for patients with symptomatic or ruptured
TAAA.
We report the 4-year follow-up of a high-risk patient with
symptomatic TAAA treated with an unusual endovascular
technique: off-label use of a device manufactured for in-
frarenal aortic aneurysm repair.ery c December 2013
